OR WAIT null SECS
Mark Eller, PhD, is senior vice-president (SVP) of Research and Development at Aria Pharmaceuticals. Eller has held several vice-president/SVP roles leading teams from discovery through approval at large and mid-sized pharma companies, including Jazz, Quintiles (now IQVIA), and HMR (now Sanofi). Eller is co-inventor on 30 patents and has led health authority presentations and negotiations, including six FDA advisory committee meetings. He has co-authored numerous scientific publications and served as an adjunct professor of Pharmaceutics at the University of Cincinnati. Eller received his Pharmacy degree and PhD in Pharmaceutics from the University of Iowa.